EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma

Baoluhe Zhang, Bao Jin iD, Xiang'an Wu, Jiali Xing, Xiao Liu iD, Xueshuai Wan, Haifeng Xu, Yiyao Xu iD, Yilei Mao iD, Qian Chen, Yating Bai, Mei Guan und 1 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Baoluhe Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study explores molecular features associated with better prognosis in cholangiocarcinoma (CCA). Methods and Results The transcriptomic and whole‐exome sequencing data obtained from paired tissues of 70 were analyzed, grouping them based on progression‐free survival (PFS), differentiation degree, and lymph node metastasis. Among the 70 patients, the TP53 gene mutation frequency was the highest (53%), while FLG gene mutation occurred exclusively in the long PFS group. In the comparison between long and short survival groups, the short PFS group exhibited higher monocyte infiltration levels ( p = 0.0287) and upregulation of genes associated with cancer‐related transcriptional misregulation, chemokine signaling, and cytokine‐cytokine receptor interactions. Differences in immune cell infiltration and gene expression were significant across differentiation and lymph node metastasis groups. Particularly noteworthy was the marked increase in CD8 T cell and NK cell infiltration ( p = 0.0291, 0.0459) in the lymph node metastasis group, significantly influences prognosis. Additionally, genes related to platinum resistance, Th17 cell differentiation, and Th1 and Th2 cell differentiation pathways were overexpressed in this group. In summary, higher monocyte infiltration levels in the short PFS group, along with elevated expression of genes associated with cancer‐related pathways, suggest a poorer prognosis. The significant increase in CD8 T cell and NK cell infiltration reflects an enhanced anti‐tumor immune response, underscoring the relevance of immune infiltration levels and gene expression in predicting outcomes for CCA patients.

Conclusions

In this study, we elucidated the pertinent molecular mechanisms and pathways that influence the prognosis of CCAs through comprehensive multi‐omics analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsMutationHumansMalePrognosisFemaleMiddle AgedRisk FactorsGene Expression Regulation, NeoplasticAgedLymphatic MetastasisExome SequencingTumor Suppressor Protein p53TranscriptomeFilaggrin ProteinsBiomarkers, TumorCD8-Positive T-LymphocytesGene Expression ProfilingProgression-Free SurvivalTumor MicroenvironmentLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

cholangiocarcinomadifferentiationimmuneintegrated multiomics analysislymphatic node transfer

Substanzen

Tumor Suppressor Protein p53Filaggrin ProteinsTP53 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Thorgene Co., Ltd., Beijing, China.
  • Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical college, Beijing, China.

ORCID-Profile: Bao Jin, Xiao Liu, Yiyao Xu, Yilei Mao, Shunda Du

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National High Level Hospital Clinical Research Funding
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zhang, B., Jin, B., Wu, X., Xing, J., Liu, X., Wan, X., Xu, H., Xu, Y., Mao, Y., Chen, Q., Bai, Y., Guan, M., & Du, S. (2024). Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70135

Vancouver

Zhang B, Jin B, Wu X, Xing J, Liu X, Wan X, et al. Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70135

BibTeX
@article{Zhang2024,
  author = {Zhang, Baoluhe and Jin, Bao and Wu, Xiang'an and Xing, Jiali and Liu, Xiao and Wan, Xueshuai and Xu, Haifeng and Xu, Yiyao and Mao, Yilei and Chen, Qian and Bai, Yating and Guan, Mei and Du, Shunda},
  title = {Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70135}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche